157 related articles for article (PubMed ID: 23136545)
1. How the duration period of erythropoietin treatment influences the oxidative status of hemodialysis patients.
Dimitrijevic ZM; Cvetkovic TP; Djordjevic VM; Pavlovic DD; Stefanovic NZ; Stojanovic IR; Paunovic GJ; Velickovic-Radovanovic RM
Int J Med Sci; 2012; 9(9):808-15. PubMed ID: 23136545
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant status and lipid peroxidation in hemodialysis patients undergoing erythropoietin and erythropoietin-vitamin E combined therapy.
Inal M; Kanbak G; Sen S; Akyüz F; Sunal E
Free Radic Res; 1999 Sep; 31(3):211-6. PubMed ID: 10499778
[TBL] [Abstract][Full Text] [Related]
3. Long-term erythropoietin therapy does not affect metalloproteinases and their inhibitor levels, oxidative stress and inflammation in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Am J Nephrol; 2007; 27(3):221-5. PubMed ID: 17384500
[TBL] [Abstract][Full Text] [Related]
4. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
[TBL] [Abstract][Full Text] [Related]
5. Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?
Sommerburg O; Grune T; Hampl H; Riedel E; van Kuijk FJ; Ehrich JH; Siems WG
Nephrol Dial Transplant; 1998 Oct; 13(10):2583-7. PubMed ID: 9794564
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress: the effect of erythropoietin and the dialysis membrane.
Eiselt J; Racek J; Opatrný K
Int J Artif Organs; 2000 Jan; 23(1):33-40. PubMed ID: 12118835
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E-bonded cellulose membrane, lipoperoxidation, and anemia in hemodialysis patients.
Triolo L; Malaguti M; Ansali F; Comunian MC; Arcangeloni O; Coppolino F; Marrocco F; Sicoli R; Biagini M
Artif Cells Blood Substit Immobil Biotechnol; 2003 May; 31(2):185-91. PubMed ID: 12751839
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment.
Siems W; Carluccio F; Radenkovic S; Grune T; Hampl H
Kidney Blood Press Res; 2005; 28(5-6):295-301. PubMed ID: 16534224
[TBL] [Abstract][Full Text] [Related]
9. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients.
Usberti M; Gerardi G; Bufano G; Tira P; Micheli A; Albertini A; Floridi A; Di Lorenzo D; Galli F
Am J Kidney Dis; 2002 Sep; 40(3):590-9. PubMed ID: 12200812
[TBL] [Abstract][Full Text] [Related]
10. Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patients.
Calò LA; Stanic L; Davis PA; Pagnin E; Munaretto G; Fusaro M; Landini S; Semplicini A; Piccoli A
Int J Clin Pharmacol Ther; 2003 May; 41(5):187-92. PubMed ID: 12776808
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E-coated polysulfone membrane improved red blood cell antioxidant status in hemodialysis patients.
Bargnoux AS; Cristol JP; Jaussent I; Chalabi L; Bories P; Dion JJ; Henri P; Delage M; Dupuy AM; Badiou S; Canaud B; Morena M
J Nephrol; 2013; 26(3):556-63. PubMed ID: 22956433
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin supplement increases plasma lipoprotein lipase and hepatic triglyceride lipase levels in hemodialysis patients.
Goto T; Saika H; Takahashi T; Maeda A; Mune M; Yukawa S
Kidney Int Suppl; 1999 Jul; 71():S213-5. PubMed ID: 10412779
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron.
Delmas-Beauvieux MC; Combe C; Peuchant E; Carbonneau MA; Dubourg L; de Précigout V; Aparicio M; Clerc M
Nephron; 1995; 69(4):404-10. PubMed ID: 7777104
[TBL] [Abstract][Full Text] [Related]
14. Lipid peroxidation and vitamin E in red blood cells and plasma in hemodialysis patients under rhEPO treatment.
Nenov D; Paskalev D; Yankova T; Tchankova P
Artif Organs; 1995 May; 19(5):436-9. PubMed ID: 7625923
[TBL] [Abstract][Full Text] [Related]
15. Oxidative damage to RBC membranes and pentose phosphate shunt activity in hemodialysis patients after suspension of erythropoietin treatment.
Taccone-Galluci M; Lubrano R; Trapasso E; Clerico A; Latorre P; Meloni C; Morosetti M; Castello MA; Casciani CU
ASAIO J; 1994; 40(3):M663-6. PubMed ID: 8555597
[TBL] [Abstract][Full Text] [Related]
16. Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients.
Agarwal R; Davis JL; Smith L
Clin J Am Soc Nephrol; 2008 Jan; 3(1):98-104. PubMed ID: 18045859
[TBL] [Abstract][Full Text] [Related]
17. Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients.
Usberti M; Gerardi G; Micheli A; Tira P; Bufano G; Gaggia P; Movilli E; Cancarini GC; De Marinis S; D'Avolio G; Broccoli R; Manganoni A; Albertin A; Di Lorenzo D
J Nephrol; 2002; 15(5):558-64. PubMed ID: 12455724
[TBL] [Abstract][Full Text] [Related]
18. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
Adamowicz A; Trafikowska U; Trafikowska A; Zachara B; Manitius J
Med Sci Monit; 2002 Mar; 8(3):CR202-5. PubMed ID: 11887037
[TBL] [Abstract][Full Text] [Related]
19. Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients?
Sommerburg O; Grune T; Hampl H; Riedel E; Ehrich JH; Siems WG
Clin Nephrol; 2000 Feb; 53(1 Suppl):S23-9. PubMed ID: 10746802
[TBL] [Abstract][Full Text] [Related]
20. Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietin.
Matsumoto Y; Amano I; Hirose S; Tsuruta Y; Hara S; Murata M; Imai T
Blood Purif; 2001; 19(1):24-32. PubMed ID: 11114574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
